A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA.

[1]  P. Haslett,et al.  A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA. , 2016, The Journal of pediatrics.

[2]  P. Haslett,et al.  A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients. , 2016, Bioanalysis.

[3]  D. Whiteman,et al.  Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome) , 2015, Orphanet Journal of Rare Diseases.

[4]  P. Haslett,et al.  Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome. , 2013, JIMD reports.

[5]  M. Heartlein,et al.  Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys , 2012, Drug Delivery and Translational Research.

[6]  M. Grootenhuis,et al.  Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome) , 2011, Orphanet journal of rare diseases.

[7]  R. Wevers,et al.  Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype‐phenotype correlations , 2010, Annals of neurology.

[8]  Alan S. Kaufman,et al.  Kaufman Assessment Battery for Children , 2010 .

[9]  D. Rapoport,et al.  Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I , 2009, Pediatrics.

[10]  J. Turner,et al.  Programmable Intrathecal Opioid Delivery Systems for Chronic Noncancer Pain: A Systematic Review of Effectiveness and Complications , 2007, The Clinical journal of pain.

[11]  C. Eng,et al.  A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) , 2006, Genetics in Medicine.

[12]  J. Wittes,et al.  Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. , 2006, The Journal of pediatrics.

[13]  M. Walker,et al.  Complications of Intrathecal Baclofen Pumps in Children , 2003, Pediatric Neurosurgery.

[14]  K. Follett,et al.  A prospective study of catheter-related complications of intrathecal drug delivery systems. , 2000, Journal of pain and symptom management.

[15]  Gary J. Robertson,et al.  Bayley Scales of Infant and Toddler Development , 2017 .